Hashimoto's encephalopathy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 41: | Line 41: | ||
* Speech problems | * Speech problems | ||
=== | ===Laboratory Findings=== | ||
====Blood and Biomarker Studies==== | |||
* Blood TSH, T3, T4 levels | * Blood [[TSH]], [[T3]], [[T4]] levels | ||
* Anti thyroid peroxidase levels | * Anti thyroid peroxidase levels | ||
Line 49: | Line 49: | ||
* CSF analysis - increased protein concentration, lymphocytic pleocytosis | * CSF analysis - increased protein concentration, lymphocytic pleocytosis | ||
===Electroencephalogram=== | ====Electroencephalogram==== | ||
* Generalized slowing of activity | * Generalized slowing of activity |
Revision as of 21:43, 3 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Synonyms and keywords: steroid-responsive encephalopathy associated with autoimmune thyroiditis, SREAT
Overview
Hashimoto's Encephalopathy is a very rare condition associated with Hashimoto's Thyroiditis. Hashimoto's Encephalopathy is a neuroendocrine disorder. Much like the antibodies in Hashimoto's Thyroiditis attack the thyroid, in Hashimoto's Encephalopathy, antibodies attack neurons in the brain.
Pathophysiology
A few theories are proposed for Hashimoto encephalopathy.
- Neuronal injury due to antibody mediated destruction.
- Immmune complex mediated vasculitis
- Toxic effect of increased thyroid stimulating hormone.
Diagnosis
Symptoms
- Concentration and memory problems
Physical examination
- Jerks in the muscles
- Lack of coordination
- Partial paralysis
- Speech problems
Laboratory Findings
Blood and Biomarker Studies
- Anti thyroid peroxidase levels
- CSF analysis - increased protein concentration, lymphocytic pleocytosis
Electroencephalogram
- Generalized slowing of activity
CT and MRI
- Non specific and show normal results
- In few patients atrophy may be seen
Differential diagnosis
Treatment
Steroids or immunosuppressant treatment, this condition is now also referred to as "steroid-responsive" encephalopathy.